Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty

40

Citations

20

References

2016

Year

Karen O. Klein, Joshua Yang, Javier Aisenberg, Nancy A. Wright, Paul B. Kaplowitz, Najiba Lahlou, Jeannete Linares, Eija Lundström, Daniela Purcea, Fernando Cassorla

Journal of Pediatric Endocrinology and Metabolism

Abstract

The triptorelin 6-month formulation was safe and effective in suppressing the pituitary-gonadal axis in children with CPP. The extended injection interval may improve compliance and increase comfort in the management of CPP.

References

	Year	Citations

Page 1